10-K/A ·Filed Apr 15, 2026
Amended annual report (potential restatement)
Actionable Insight • Neutral
No trading action is warranted. This is a routine administrative filing to complete the annual report. Traders should focus on the original 10-K and future operational results.
Final — all horizons settled through T+60d
CTSO ▼ -37.70% at T+60d
NEUTRAL call -37.70% · α vs SPY -44.75% · entry $0.6100 → $0.3800
T+1d
+8.20%
call +8.20% · α +6.98%
$0.6600
settled 6mo ago
T+5d
+6.23%
call +6.23% · α +5.25%
$0.6480
settled 6mo ago
T+20d
-6.39%
call -6.39% · α -12.21%
$0.5710
settled 6mo ago
T+60d
-37.70%
call -37.70% · α -44.75%
$0.3800
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Cytosorbents Corp filed an amended 10-K/A solely to include Part III disclosures (directors, executive compensation, related parties) and updated Sarbanes-Oxley Section 302 certifications. No financial statements were amended or restated. This is a routine administrative filing.
Key Facts
- Amendment was filed solely to include Part III of Form 10-K (directors, executive compensation, related parties).
- No financial statements were amended or restated.
- Updated Section 302 certifications from CEO and CFO were included.
- No material changes to financial condition, operations, or disclosures were made.
Financial Impact
None. No financial statements were amended.
Risk Factors
- None identified from this filing. The amendment itself is non-material.
Market Snapshot
Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001104659-26-043852 |
| Document: ctso-20251231xex31d1.htm | 0001104659-26-043852 |
| Document: ctso-20251231xex31d2.htm | 0001104659-26-043852 |
| Document: 0001104659-26-043852-index-headers.html | 0001104659-26-043852 |
| Document: 0001104659-26-043852-index.html | 0001104659-26-043852 |
| Document: 0001104659-26-043852.txt | 0001104659-26-043852 |
6 reports for CTSO
33% Hit rate @ T+20 Went positive at some point 2 of 3 best @ T+60▲ +35.85%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 8-K | $4.91 $5.35 | ▲ +8.96% | ▲ +8.27% | $4.49 (−8.45%) |
Aug 6, 2026 11w ago | Press Release | $0.3600 $0.3501 | ▲ +2.75% | ▲ +2.35% | $4.49 (−1148.61%) |
Jun 25, 2026 17w ago | DEFA14A | $0.3620 $0.3600 | ▼ −0.55% | ▼ −1.94% | $4.49 (+1141.71%) |
Jun 16, 2026 19w ago | Insider Cluster | $0.5189 $0.3694 | ▼ −28.81% | ▼ −28.86% | $4.49 (+766.26%) |
Apr 15, 2026 27w ago | 10-K/A | $0.6100 $0.5710 | ▼ −6.39% | ▼ −12.21% | $4.49 (+636.89%) |
Apr 2, 2026 29w ago | 8-K | $0.5830 $0.6100 | ▼ −4.63% | ▲ +5.25% | $4.49 (−671.01%) |
Showing 6 of 6
US Market Status
Market Open — Closes in 2h 16m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers